HIPACE High Frequency Low Energy Pacing to Terminate Fast Ventricular Arrythmias

Arrhythmias Clinical Trial

— HIPACE  

Official title:

High Frequency Low Energy Pacing to Terminate Fast Ventricular Arrythmias

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02629445
• Other study ID #: CD14/11241
• Status: Completed
• Phase: N/A
• Start date: November 2015
• Est. completion date: July 29, 2016

Study information

• Verified date: February 2019
• Source: The Leeds Teaching Hospitals NHS Trust
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

People that have survived, or are at high risk of a lifethreatening ventricular arrhythmia are routinely offered a defibrillator (ICD). An ICD is an implanted device which can recognise a ventricular arrhythmia and then try to treat it, either by rapidly pacing the heart or by shocking the heart. Currently, very fast ventricular arrhythmias, known as VF, can only be treated with a shock. Patients find shocks painful and this study is intended to find out whether it is possible to pace the heart at very high rates during VF. It is hoped that if this is possible, further research could lead to effective treatment of VF with pacing rather than shocks, and therefore better outcomes for patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 8
• Est. completion date: July 29, 2016
• Est. primary completion date: July 29, 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria:

• Patient is older than 18 years of age; Any patient with a Medtronic cardiac implantable defibrillator undergoing defibrillation testing; No contra indication to defibrillation testing Patient is able to give informed consent.

Exclusion Criteria:

• Patient is younger than 18 years; Patient is not able to give informed consent or is unwilling to participate in the study; Patient has a contraindication to defibrillation testing

Related Conditions & MeSH terms

• Arrhythmias

Intervention

Device:
• Cardiac Resynchronisation Defibrillator
Defibrillation testing of cardiac defibrilator

Locations

Country	Name	City	State
United Kingdom	Leeds Teaching Hospitals NHS Trust	Leeds	West Yorkshire

Sponsors (1)

Lead Sponsor	Collaborator
The Leeds Teaching Hospitals NHS Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Rapid pacing of the heart	The primary outcome measure is to determine whether it is possible to obtain ventricular capture of the heart by repetitive pacing at very high rates during ventricular fibrillation.	10 seconds